Clarity in cell line development

Solentim Wins Place in Deloitte UK Technology Fast 50

Solentim named as one of the top 50 fastest growing UK technologies companies of 2018 16th November 2018 / Solentim, a life sciences company, has won a place in this year’s Deloitte’s UK Technology Fast 50 list following a 1,106% revenue growth over the past 4 years. Solentim specialises in products used by developers of new …

Read more Solentim Wins Place in Deloitte UK Technology Fast 50

Solentim Wins Two Queen’s Awards for Enterprise

Solentim’s business excellence and expertise in cell line development recognised with awards, for both International Trade and Innovation Wimborne, UK, 8th October 2018 / Solentim, a leading provider of instrumentation used by biopharma companies in the fields of mammalian cell line development and cell culture, has received two Queen’s Awards for Enterprise, one for International Trade and one …

Read more Solentim Wins Two Queen’s Awards for Enterprise

The changing workflows of cell line development – Quality, not Quantity

Damp weather did little to suppress the energy in the rooms at last week’s 10th Annual BioProcessing Summit in Boston. There were over 1,000 delegates, including many from the US West Coast and Europe, all there to listen, learn, and participate in what promised to be a valuable week. With seven parallel sessions running through …

Read more The changing workflows of cell line development – Quality, not Quantity

Technology facilitating single cell cloning to help meet regulatory requirements

Patricia Fitzpatrick Diamond discusses recent technological advances aiding single cell cloning, including Solentim’s VIPS™, in GEN. To meet regulatory standards, recombinant proteins must be produced from a single cell line, demonstrating monoclonality whilst maintaining viability. This is a slow and involved process, with commonly used methods exhibiting significant draw backs. Limiting dilution retains the viability …

Read more Technology facilitating single cell cloning to help meet regulatory requirements

Janssen Pharma to present VIPS data at major conference

Customer data presentation at the Bioprocessing Summit in Boston NEWS – Bournemouth, UK – 30th July, 2018: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce that Janssen Pharmaceutical (part of Johnson & Johnson) will be presenting data from the VIPS single cell seeding platform at the forthcoming CHI 10th Annual Bioprocessing Summit in Boston. …

Read more Janssen Pharma to present VIPS data at major conference

Solentim at the Palace

This week, members of Solentim’s management team enjoyed the privileged experience of visiting Buckingham Palace. The invitation to a private reception at the Palace followed Solentim’s success in winning two Queen’s Awards for Enterprise, announced in April, the first for Innovation and the second for International Trade. The reception was hosted by The Prince of …

Read more Solentim at the Palace